Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

GlobalData automotive analysts use AI to guide clients and anticipate market shifts

LONDON, 28 October 2025 – As electrification, regulatory shifts, and evolving consumer expectations continue to redefine the global automotive industry, navigating uncertainty demands both data precision and human insight. GlobalData Plc, the trusted intelligence partner to leading organizations worldwide, empowers clients through its artificial intelligence (AI)-enhanced Automotive Intelligence Solution, where advanced technology amplifies the depth […]
Read more

Cyber insurance demand surges amid heightened geopolitical tensions, reveals GlobalData

Cyber insurance has emerged as the most in-demand insurance product as escalating geopolitical tensions drive a surge in cyber threats. With conflicts increasingly extending into cyberspace, organizations are prioritizing stronger digital resilience, while insurers focus on providing clearer coverage and faster recovery support to meet the growing complexity of cyber-related risks, reveals the latest poll […]
Read more

Global deal activity down by 4% YoY during Q1-Q3 2025 as cautiousness prevails, finds GlobalData

Global deal activity has experienced a decline during the first three quarters (Q1-Q3) of 2025, reflecting a shift in deal-making sentiments amid ongoing economic uncertainties. The total number of deals (comprising mergers & acquisitions (M&A), private equity and venture financing deals) announced globally fell by around 4% during Q1-Q3 2025 compared to the same period […]
Read more

Breast Cancer Awareness Month: Early identification can close gap in breast cancer care, says GlobalData

Breast cancer is the most diagnosed cancer in women worldwide. Raising awareness encourages early detection through mammography. As October is Breast Cancer Awareness Month, community outreach should be prioritized to bring awareness to anyone who may be affected by breast cancer. Early detection significantly increases the chances of successful treatment and survival. The stage of […]
Read more

China to account for 60% of upcoming petrochemicals project starts in Asia by 2030, says GlobalData

Asia is poised to dominate the global petrochemicals projects landscape, representing for nearly two-thirds of the projects slated to commence operations by the end of the decade. China is likely to account for more than 60% of them, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Petrochemicals New-Build and Expansion Projects […]
Read more

Australia defense budget poised to grow at 5.9% CAGR between 2026 and 2030, forecasts GlobalData

Amidst escalating tensions in the Indo-Pacific, shifting geopolitical fault lines and growing strategic competition, Australia is accelerating efforts to modernize its military. Against this backdrop, Australia’s defense budget is set to increase at a compound annual growth rate (CAGR) of 5.9% from $44.6 billion in 2026 to $56.2 billion in 2030, driven in large part […]
Read more

CMS top M&A legal adviser by volume in automotive sector during Q1-Q3 2025, while Clifford Chance, De Brauw, Greenberg Traurig, Maisto e Associati, and PedersoliGattai led by value, finds GlobalData

CMS was the top mergers and acquisitions (M&A) legal adviser in the automotive sector during the first three quarters (Q1-Q3) of 2025 by volume, whereas Clifford Chance, De Brauw Blackstone Westbroek (De Brauw), Greenberg Traurig, Maisto e Associati, and PedersoliGattai jointly held the top position by value, according to the latest legal advisers league table […]
Read more

Goldman Sachs and Lazard top M&A financial advisers in automotive sector during Q1-Q3 2025, finds GlobalData

Goldman Sachs and Lazard were the top mergers and acquisitions (M&A) financial advisers in the automotive sector during the first three quarters (Q1-Q3) of 2025 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database revealed that […]
Read more

JP Morgan and Rothschild & Co top M&A financial advisers in power sector during Q1-Q3 2025, reveals GlobalData

JP Morgan and Rothschild & Co were the top mergers and acquisitions (M&A) financial advisers in the power sector during the first three quarters (Q1-Q3) of 2025 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database […]
Read more

Kirkland & Ellis and Latham & Watkins top M&A legal advisers in retail sector during Q1-Q3 2025, finds GlobalData

Kirkland & Ellis and Latham & Watkins were the top mergers and acquisitions (M&A) legal advisers in the retail sector during the first three quarters (Q1-Q3) of 2025 by value and volume, respectively, according to the latest legal advisers league table by GlobalData,  a leading data and analytics company. An analysis of GlobalData’s Financial Deals […]
Read more

GlobalData highlights potential impact of AI-powered bio-wearables on in vitro diagnostics

The convergence of biosensing and artificial intelligence (AI) is redefining remote patient care, with next-gen bio-wearables enabling continuous molecular monitoring beyond traditional in vitro diagnostics (IVD). The latest $14 million funding round by Adaptyx Biosciences (Adaptyx) for its AI-powered bio-wearable skin patch signals growing investor confidence in technologies that could transform episodic testing into proactive, […]
Read more

Japan biopsy devices market to grow at 3% CAGR through 2036, forecasts GlobalData

With rising cancer prevalence and greater adoption of minimally invasive and image-guided diagnostic procedures, the biopsy devices market in Japan is projected to expand at a compound annual growth rate (CAGR) of 3% through 2036, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions […]
Read more

Novartis strengthens IgAN position with Fabhalta trial results, says GlobalData

Novartis recently announced positive final results from the Phase III APPLAUSE-IgAN clinical trial, demonstrating that Fabhalta (iptacopan) significantly slows kidney function decline in adults with IgA nephropathy (IgAN). The results establish Fabhalta as the first and only approved complement inhibitor for the progressive autoimmune kidney disease, strengthening Novartis’ position in the IgAN space, says GlobalData, […]
Read more
1 … 35 36 37 38 39 … 770